The Technology and Business Development Office (TBDO) is made of professionals with strong, and complementary scientific and business backgrounds. Determination, integrity and passion for what we do are the main drivers of our work. We are currently a team of four, supported by an administrative assistant:
About us
The mission of the Technology and Business Development Office (TBDO) at CRG is to facilitate the exploitation of the institution’s research results for the public good, and to help the economic growth of the life sciences sector in our region. Our will is that scientific results generated at CRG will develop into novel therapeutic, diagnostic and other type of products that will contribute to the wellness of our society. Read More / Less
We are responsible for materializing CRG’s-based efforts at capturing the value emanating from CRG’s research activities by:
- Identifying and assessing the market potential of innovations, discoveries and inventions made at CRG
- Securing the necessary property rights
- Managing CRG´s proof of concept fund and related initiatives
- Acting as a liaison between CRG’s innovations and researchers, and industry
- Marketing and licensing CRG’s know-how and technologies through the negotiation and execution of licensing agreements, and the creation of spin-off companies
- Creating additional value through other intellectual property-related transactions, including but not limited to consultancy, sponsored research and services
- Stimulating innovation and entrepreneurship within the CRG community through different types of activities
Anabel Sanz, Ph.D.
Head of the Technology and Business Development Office (TBDO)
Anabel has broad experience in evaluation of technologies in life sciences, intellectual asset management, licensing, business development and new ventures. Since 2010, she has held managerial positions in technology transfer at three research excellence centers in Spain, CNB-CSIC (Biotechnology), CNIO (Cancer) and since 2019, at CRG (Genomics). Previously she worked for more than a decade in a spin-off (CropDesing) of the Flemish Institute for Biotechnology (VIB) and in the multinational company BASF. She has implemented innovation processes and successfully supported establishment of numerous public-private research partnerships and IPR transactions. A chemist by training, she holds a Master’s in Science from the U. Wales, UK, a PhD in Biology from the Autonomous University in Madrid (ES), postdoctoral experience in Spain and Belgium and an Executive Master in Science and Technology Business from IE business school.
Silvia Tórtola, Ph.D.
Senior Business Development Manager
Silvia graduated in Biology from the University of Barcelona, and holds a Master in Immunology and a Ph.D. in Biology from the same institution. From 1998 to early 2002, she was research fellow at the Fondation pour Recherches Médicales (University of Geneva, Switzerland), working on fundamental questions of gene regulation and cancer. In 2002, she moved to Germany to work as a scientist at the biotech start-up company Europroteome AG (of which she was also founder member), focused on the development of diagnostic and prognostic tools as well as patient-specific therapies for human epithelial cancers. Late in 2005, she moved back to Barcelona to initiate the technology transfer activities at CRG, where she is also a member of the Ethical Committee of Clinical Research.
Peter Stienen, PhD.
Translational Research Manager
Peter graduated in Biology from Radboud University Nijmegen, and obtained his Ph.D. from the Faculty of Veterinary Medicine at Utrecht University (The Netherlands) with a focus on pharmacology and electrophysiology. After a postdoctoral period in the same institution, he switched from academia to pharmaceutical industry in 2008. In the last 7 years, he has worked in different companies, ranging from small spin-off biotech to big pharma companies such as Ferrer Internacional (Spain) and AstraZeneca (Sweden). During these years, he worked in Research & Development towards the discovery and (pre)clinical development of potential new medicines, applying and gaining expertise in combining different technical platforms including pharmacology, electrophysiology, pharmacokinetics and imaging. In 2015 he joined the TBDO as Translational Research Manager, where his main role consists of designing and managing appropriate experimental studies and projects to bridge the gap(s) between research and commercialization.
Diana Domínguez, Ph.D.
New Ventures Manager
Diana is a highly accomplished professional in the field of biomedical sciences, with expertise in cancer immunotherapies and metabolism. She has a strong educational background, with a degree in Biomedical Sciences from the Universitat de Barcelona and an MRes in Translational Cancer Medicine from King's College London. Her research has primarily focused on cancer immunotherapies. Diana further advanced her academic career by obtaining a Ph.D. in Biomedicine from the Universitat Pompeu Fabra, specializing in cancer metabolism and the underlying transcriptomic and epigenetic events of metastasis. After a short post-doctoral period at IRB, Diana joined CRG in 2021 as an Innovation Facilitator, responsible for promoting collaboration between the research community and innovation stakeholders, initiating new projects, and identifying funding opportunities within the Horizon Europe program. In December 2022, she transitioned into the role of CRG New Ventures Manager, where she focuses on business development initiatives to create value and facilitate the exploitation of CRG technologies.
Michael Potter
Innovation and Industry Manager
Michael is a chemist by background, graduating from the University of Southampton, UK, in 2015 with a Masters in Chemistry. He holds a PhD (2021) in Chemical Biology from Imperial College London, his work focusing on the design of lipid and dendritic nanomaterial systems for antibacterial applications. These years included a post working at the UK Parliamentary Office of Science and Technology where he worked on preparing non-expert briefings for parliamentarians and the general public, far from his PhD focus, where he gained experience managing a project across many stakeholder groups. Following these years, he relocated to Barcelona, where he worked at ISGlobal as Preaward Innovation Manager until January 2022 with the aim of supporting researchers in preparation of proof-of-concept and innovation proposals and mapping the innovation landscape internally. Since February 2022, he has been working at the CRG as Industry and Innovation Manager where he is building a career in academic technology transfer. His primary focus is to scout for industrial partners and facilitate new research partnerships between the CRG and external companies. He is open to all approach from all companies, large or small, interested in building fruitful partnerships with the CRG.
Laia Subirana
Office Manager
Laia graduated in Biology from the University of Barcelona, has a Bachelor's degree in Business Sciences from Universitat Oberta de Catalunya and a Master's degree in Pharmateutical Marketing from EADA. Before joining the CRG she worked in the Universitat Pompeu Fabra as a Lab Manager and Research Assistant to various research groups, including Cell Signaling, Developmental Biology, Cancer Biology and Live-cell structural Biology. Prior to her work at the Universitat Pompeu Fabra, Laia worked on various projects related to transfusional medicine at the Centre de Transfusió I Banc de Teixits.
Eylem Aydoğdu
Business Development Manager and IP Advisor
Eylem is an accomplished professional with a strong research background, holding a Ph.D. in Biochemistry from the University of Houston, USA, her research focusing on gene regulation in breast cancer and cancer stem cells. Following her doctoral studies, she spent over five years as a Postdoctoral Researcher at VIB in Belgium, delving into genomic foundations of polyploid cell evolution, further broadening her expertise in molecular biology, genomics and bioinformatics. Her diverse professional journey also includes serving as the Country Project Coordinator for the Stent for Life European Cardiology Project in Turkey (now global Stent-Save a Life), as a Technology Transfer Officer at VIB and, most recently, as a Patent Adviser for an intellectual property firm specializing in biotechnology. In September 2023, she joined TBDO as Business Development Manager and IP Advisor, contributing her skills to further enhance the team's ongoing efforts in facilitating the transition of innovative technologies from research to the commercial world.
We have strong links to many other technology transfer offices and networks worldwide, being proud members of a number of professional associations, namely:
- ASTP-Proton, the pan-European association for professionals involved in knowledge transfer between universities and public research institutions and industry
- AUTM, the US-based Association of University Technology Managers
- EU-Life, an alliance of top research centres in life sciences to support and strengthen European research excellence, structured around different working groups, including one devoted to Technology Transfer
- RedOTRI, the Spanish network of technology transfer offices from universities and public research institutions
The TBDO also benefits from the expert advice of a Business Board that is made up of representatives from local and international biotech and pharma companies, venture capital, a business school and the economics press. The Board meets once a year to guide and advice the institution in general and the TBDO in particular, about different initiatives to help bridge the gap between science and society, and science and industry.
Through the years we have also engaged ourselves in countless partnerships and collaborations with some of the main stakeholders in the biomedical field.